Nearest companies
Gamgee and the companies nearest it
Grouped on biotechnology, genomics, oncology — sectors these companies actually share, not a category everything is in.
MentionFox
The full picture on any company
→ What to offer to acquire them — and the evidence that justifies the number
→ Which of their people to hire first, and what it'll take to move them
→ What to put in the contract before you sign
→ Where they're weak enough that you can take their customers
Get the good, the bad, and the ugly — before you sign anything
A real report, on a company with a page right here.
Show me →
FoxPlug
Build your launch kit from your URL
yourdomain.com Build
Enter yours on FoxPlug — this one is a picture of the box.
Your analytics tell you what happened. FoxPlug tells you what to do about it.
Make my launch kit →
It follows you to every device, instead of living in this browser.
Everything else you save from these pages lands in the same list.
Nothing is emailed to you unless you switch it on yourself.
Saved here on this device in the meantime, so nothing is lost either way.
Paste this where you want the card to appear
Copy snippet
← Prev
Next →
1 of 8
Y Combinator · Summer 2026
Gamgee
Scalable Personalised Cancer Treatment
1 of 8
Gamgee
New accelerator entry · 2026-07-22 · the record
United States of America
region
Bar compares stated amounts only. A raise with no amount on the record is left out rather than counted as zero.
Open the record →
10%
percentile
2
people — bigger than that share of the Summer 2026 batch
Against the 209 companies on file from Summer 2026. Median team 2, largest 30.
View full profile ↗
Y Combinator · Summer 2026
Omanta
A research lab for one
2 of 8
Omanta
New accelerator entry · 2026-08-03 · the record
United States of America
region
Bar compares stated amounts only. A raise with no amount on the record is left out rather than counted as zero.
Open the record →
83%
percentile
5
people — bigger than that share of the Summer 2026 batch
Against the 209 companies on file from Summer 2026. Median team 2, largest 30.
View full profile ↗
Form D · 2026-09-03
Superluminal Medicines, Inc.
3 of 8
Superluminal Medicines, Inc.
New Form D on file · 2026-09-03 · the record
$65.48M
raise on the record
Bar compares stated amounts only. A raise with no amount on the record is left out rather than counted as zero.
Open the record →
100%
percentile
$65.48M
of raises in its group are smaller
Against the 5 raises on file in Biotechnology. Median $5.09M, largest $65.48M.
Offering size, this raise against its peers
Superluminal Medicines, Inc.
$65.48M
Bars are to scale against $65.48M, the largest of the six. The dotted line is the median of all 5 raises on file in Biotechnology. Amounts are what each filing states as sold, or as the total offering where nothing is recorded sold yet.
View full profile ↗
Form D · 2026-09-04
Gossamer Bio, Inc.
4 of 8
Gossamer Bio, Inc.
New Form D on file · 2026-09-04 · the record
Bar compares stated amounts only. A raise with no amount on the record is left out rather than counted as zero.
Open the record →
75%
percentile
$25M
of raises in its group are smaller
Against the 5 raises on file in Biotechnology. Median $5.09M, largest $65.48M.
Offering size, this raise against its peers
Bars are to scale against $65.48M, the largest of the six. The dotted line is the median of all 5 raises on file in Biotechnology. Amounts are what each filing states as sold, or as the total offering where nothing is recorded sold yet.
View full profile ↗
Form D · 2026-09-04
Immunophotonics, Inc.
5 of 8
Immunophotonics, Inc.
New Form D on file · 2026-09-04 · the record
$10.15M
raise on the record
Bar compares stated amounts only. A raise with no amount on the record is left out rather than counted as zero.
Open the record →
Offering size, this raise against its peers
Immunophotonics, Inc.
$10.15M
Bars are to scale against $65.48M, the largest of the six. Amounts are what each filing states as sold, or as the total offering where nothing is recorded sold yet.
View full profile ↗
Form D · 2026-09-04
Episteme Prognostics, Inc.
6 of 8
Episteme Prognostics, Inc.
New Form D on file · 2026-09-04 · the record
$5.09M
raise on the record
Bar compares stated amounts only. A raise with no amount on the record is left out rather than counted as zero.
Open the record →
25%
percentile
$5.09M
of raises in its group are smaller
Against the 5 raises on file in Biotechnology. Median $5.09M, largest $65.48M.
Offering size, this raise against its peers
Episteme Prognostics, Inc.
$5.09M
Bars are to scale against $65.48M, the largest of the six. The dotted line is the median of all 5 raises on file in Biotechnology. Amounts are what each filing states as sold, or as the total offering where nothing is recorded sold yet.
View full profile ↗
Form D · 2026-09-04
Pluri Inc.
7 of 8
Pluri Inc.
New Form D on file · 2026-09-04 · the record
$3.68M
raise on the record
Bar compares stated amounts only. A raise with no amount on the record is left out rather than counted as zero.
Open the record →
0%
percentile
$3.68M
of raises in its group are smaller
Against the 5 raises on file in Biotechnology. Median $5.09M, largest $65.48M.
Offering size, this raise against its peers
Bars are to scale against $65.48M, the largest of the six. The dotted line is the median of all 5 raises on file in Biotechnology. Amounts are what each filing states as sold, or as the total offering where nothing is recorded sold yet.
View full profile ↗
Form D · 2026-09-03
Inventure, LLC
8 of 8
Inventure, LLC
New Form D on file · 2026-09-03 · the record
Bar compares stated amounts only. A raise with no amount on the record is left out rather than counted as zero.
Open the record →
Offering size, this raise against its peers
Bars are to scale against $65.48M, the largest of the six. One or more bars are drawn at their minimum width because the raise is too small to render against the largest — read the figure, not the bar. Amounts are what each filing states as sold, or as the total offering where nothing is recorded sold yet.
View full profile ↗
Use the arrow keys, or swipe, to move between companies. Every figure is read from the source record each company links to.
A deck arranges pages that already exist; it states nothing the individual profiles do not. Figures are read directly from the source record; names have not been matched against other people.
